Connect your AI

Pacira BioSciences, Inc. PCRX Interest Paid

Interest Paid at other companies

Avanos MedicalAVNS

$1.63M-43.5%

Collegium Pharmaceutical, Inc.COLL

$22.11M+1.9%

AtriCureATRC

$1.22M-2.1%

Other financials

Income statement

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

Market cap$942.78M-16.0%

Enterprise value$1.21B+1.2%

P/E183.5×—

P/S1.3×-0.3×

Profitability

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pacira BioSciences, Inc.'s interest paid?: Pacira BioSciences, Inc. (PCRX) reported interest paid of $1.6M in Q1 2026.
How has Pacira BioSciences, Inc.'s interest paid changed year-over-year?: Pacira BioSciences, Inc.'s interest paid decreased by 41.3% year-over-year, from $2.72M to $1.6M.
What is the long-term trend for Pacira BioSciences, Inc.'s interest paid?: Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s interest paid has grown at a 21.5% compound annual growth rate (CAGR), from $7M to $15.24M.
What does interest paid mean?: Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.